Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 132

Results For "CEO"

1788 News Found

Uniphore and SpinSci join hands to improve patient access and engagement
Digitisation | March 15, 2022

Uniphore and SpinSci join hands to improve patient access and engagement

Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences


IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster
People | March 15, 2022

IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster

He has over 25 years of rich experience in marketing and business in various sectors


Exergen Medical expands presence in India
Medical Device | March 15, 2022

Exergen Medical expands presence in India

The TAT-5000 and the TAT-2000 thermometers for professional use by doctors and nurses and the TAT-2000C thermometer for consumer applications are based on a very innovative infrared technology


Ascletis increases ritonavir production capacity to 530 million tablets a year
Biotech | March 14, 2022

Ascletis increases ritonavir production capacity to 530 million tablets a year

Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)


USFDA clears Niramai's breast thermography device
News | March 14, 2022

USFDA clears Niramai's breast thermography device

The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region


BioPharma’s Herceptin biosimilar Phase 3 results positive
Biotech | March 12, 2022

BioPharma’s Herceptin biosimilar Phase 3 results positive

The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile


AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases
Biotech | March 11, 2022

AbbVie and Gedeon Richter to collaborate on neuropsychiatric diseases

Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products


Emmes acquires Casimir, its fourth major acquisition
Biotech | March 11, 2022

Emmes acquires Casimir, its fourth major acquisition

Casimir further differentiates Emmes’ industry-leading rare disease research capabilities


First-in-human trial in US for Gan & Lee type 2 diabetes drug
Biotech | March 11, 2022

First-in-human trial in US for Gan & Lee type 2 diabetes drug

The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers


Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics
News | March 10, 2022

Everlife acquires Research Instruments to boost presence in life science and clinical diagnostics

The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months